BPBT
BRLI

Boston Private Bank & Trust’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Boston Private Bank & Trust’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8,000
Closed -$224K – 1225
2014
Q3 		$224K Hold
8,000
– – 0.01% 382
2014
Q2 		$242K Hold
8,000
– – 0.01% 371
2014
Q1 		$221K Hold
8,000
– – 0.01% 386
2013
Q4 		$204K Hold
8,000
– – 0.01% 393
2013
Q3 		$239K Sell
8,000
-1,500
-16% -$41.7K 0.01% 361
2013
Q2 		$273K Buy
+9,500
New +$262K 0.02% 334

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boston Private Bank & Trust's BRLI Position: Q4 2014 in Review

Boston Private Bank & Trust sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q4 2014, closing a stake of 8,000 shares — an estimated $224K sold.

Boston Private Bank & Trust first reported a position in BRLI in Q2 2013 and held it in 6 quarters. The position peaked at $273K in Q2 2013. 182 funds tracked by Wall St. Rank hold BRLI as of Q4 2014.

  • Boston Private Bank & Trust reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q4 2014 after selling out during the quarter.
  • Boston Private Bank & Trust sold 8,000 BIO-REFERENCE LABS INC-NEW- shares in Q4 2014, an estimated $224K.
  • Boston Private Bank & Trust first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 6 quarters.
  • Boston Private Bank & Trust's BIO-REFERENCE LABS INC-NEW- position peaked at $273K in Q2 2013.
  • 182 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q4 2014.

Based on Boston Private Bank & Trust's 13F filing for Q4 2014, filed 12 Jan 2015.